(Q41707998)

7 October 2017

title

Secretory leukocyte protease inhibitor (SLPI): oxidation of SLPI does not explain its variable anti-HIV activity (English)

1 reference

7 October 2017

K Konopka

1

1 reference

7 October 2017

N Shine

series ordinal

2

1 reference

7 October 2017

E Pretzer

series ordinal

3

1 reference

7 October 2017

N Düzgüneş

series ordinal

4

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

Journal of Dental Research

7 October 2017

published in

1 reference

7 October 2017

volume

78

1 reference

7 October 2017

issue

12

1 reference

7 October 2017

page(s)

1773-1776

1 reference

Oxidized mucus proteinase inhibitor: a fairly potent neutrophil elastase inhibitor.

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00220345990780120201

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345990780120201

Liposomes modulate human immunodeficiency virus infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345990780120201

Human immunodeficiency virus type-1 (HIV-1) infection increases the sensitivity of macrophages and THP-1 cells to cytotoxicity by cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345990780120201

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345990780120201

CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345990780120201

Inhibition of human immunodeficiency virus type-1 replication in macrophages and H9 cells by free or liposome-encapsulated L-689,502, an inhibitor of the viral protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345990780120201

Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345990780120201

The anti-HIV-1 activity associated with saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345990780120201

Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345990780120201

Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345990780120201

10.1177/00220345990780120201

21 January 2018

Identifiers

DOI

1 reference

7 October 2017

1 reference